MARIE MURRAY: Open Payments
NPI 1942766456 · NEWPORT, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$787 in 35 payments from 6 companies in 2025. Trend: 2023 $437 · 2024 $493 · 2025 $787
Food & beverage: $787
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $385 |
| ABBVIE INC. | 11 | $186 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $157 |
| Aimmune Therapeutics, Inc. | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $14 |
Products named: TREMFYA, ENTYVIO, RINVOQ, SKYRIZI, VOWST, XIFAXAN, OMVOH.
Industry payments across RI — which companies pay providers there.
